Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Location
131 Dartmouth Street, 3 Rd Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790 % -30.9%
Debt-to-equity 21.1 % +32.1%
Return On Equity -77.9 % -44.7%
Return On Assets -64.4 % -38.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 153M shares +86%
Common Stock, Shares, Outstanding 83.3M shares +1.04%
Entity Public Float 84.4M USD +10%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 91.1M shares +0.26%
Weighted Average Number of Shares Outstanding, Diluted 91.1M shares +0.26%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 97.4M USD -3.42%
General and Administrative Expense 23.6M USD -14.6%
Operating Income (Loss) -121M USD +5.81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -115M USD +2.44%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -115M USD +2.44%
Earnings Per Share, Basic -1 USD/shares +26.5%
Earnings Per Share, Diluted -1 USD/shares +26.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.1M USD -72.4%
Other Assets, Current 619K USD +14%
Assets, Current 106M USD -48.4%
Property, Plant and Equipment, Net 18M USD -25.3%
Operating Lease, Right-of-Use Asset 11.9M USD -20.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 110K USD -78.3%
Assets 140M USD -42.9%
Accounts Payable, Current 4.29M USD +71.5%
Employee-related Liabilities, Current 6.17M USD +1.03%
Liabilities, Current 18.9M USD -2.34%
Operating Lease, Liability, Noncurrent 11.6M USD -22%
Other Liabilities, Noncurrent 125K USD +7.76%
Liabilities 31.3M USD -8.99%
Accumulated Other Comprehensive Income (Loss), Net of Tax 56K USD -53.7%
Retained Earnings (Accumulated Deficit) -584M USD -24.5%
Stockholders' Equity Attributable to Parent 109M USD -48.4%
Liabilities and Equity 140M USD -42.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD -11.2%
Net Cash Provided by (Used in) Financing Activities -104K USD -100%
Net Cash Provided by (Used in) Investing Activities -2.86M USD -1097%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 83.3M shares +1.04%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -28.4M USD -132%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32M USD -69.7%
Deferred Tax Assets, Valuation Allowance 119M USD +20.4%
Deferred Tax Assets, Gross 122M USD +19%
Operating Lease, Liability 14.6M USD -19.9%
Depreciation 6.53M USD -1.26%
Payments to Acquire Property, Plant, and Equipment 1.49M USD +524%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -115M USD +11.9%
Lessee, Operating Lease, Liability, to be Paid 17.2M USD -22.1%
Property, Plant and Equipment, Gross 43.9M USD +0.29%
Operating Lease, Liability, Current 2.93M USD -10.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.59M USD -32.4%
Deferred Tax Assets, Operating Loss Carryforwards 74.8M USD +14.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 26.4M USD +42.8%
Operating Lease, Payments 900K USD -40%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.66M USD +4.76%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 5.02M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 3M USD -18.3%
Share-based Payment Arrangement, Expense 12.4M USD -47%
Operating Leases, Future Minimum Payments, Due in Three Years 4.01M USD -2.12%
Operating Leases, Future Minimum Payments Due 27M USD -2.15%
Interest Expense 13K USD +225%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%